Theravance Biopharma Inc. (TBPH) Rose 6.06% or 1.38 To Price $24.16 On Tuesday

Theravance Biopharma Inc. (TBPH) rose 6.06% or 1.38 to $24.16. It is near to 281598 shares traded, which is 116.04% compare to the average total volume 242679. The market cap of TBPH is $1.32 billion. The year to date change is -18.85%. The 52 week price range is from $22.09 to $43.44. Price of TBPH have changed 0.18% during last week. It have changed -12.82% over last month, -13.91% over last 3 months, -30.51% over last 6 months and -39.50% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TBPH is 26.49. It is 9.64% above current price. The 200-day Moving Averages for TBPH is 29.82. It is 23.43% above current price. The 52-week High is 43.44. It is 79.80% from the current price. The 52-week Low is 22.09. It is -8.57% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of TBPH is 21.25 on 2018-03-29. Short % to float is 11.77%. There are some statistics of TBPH. It is has market cap $1.32 billion. The share outstanding is 54.80 million. The average volume is 242679. The revenue is 10.87M. The gross profit is 7.96M. The percent of top 15 Institution holding is 84.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TBPH is -122.65%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TBPH is -52.82%.


Share this post